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Abstract:  A  primary  focus  of  neurointensive  care  is  the  prevention  of 
secondary brain injury, mainly caused by ischemia. A noninvasive bedside 
technique for continuous monitoring of cerebral blood flow (CBF) could 
improve  patient  management  by  detecting  ischemia  before  brain  injury 
occurs.  A  promising  technique  for  this  purpose  is  diffuse  correlation 
spectroscopy  (DCS)  since  it  can  continuously  monitor  relative  perfusion 
changes  in  deep  tissue.  In  this  study,  DCS  was  combined  with  a  time-
resolved near-infrared technique (TR-NIR) that can directly measure CBF 
using indocyanine green as a flow tracer. With this combination, the TR-
NIR  technique  can  be  used  to  convert  DCS  data  into  absolute  CBF 
measurements. The agreement between the two techniques was assessed by 
concurrent measurements of CBF changes in piglets. A strong correlation 
between  CBF  changes  measured  by  TR-NIR  and  changes  in  the  scaled 
diffusion coefficient measured by DCS was observed (R
2 = 0.93) with a 
slope of 1.05 ± 0.06 and an intercept of 6.4 ± 4.3% (mean ± standard error). 
© 2011 Optical Society of America 
OCIS codes: (170.1470) Blood or tissue constituent monitoring; (170.3660) Light propagation 
in tissues; (170.3890) Medical optics instrumentation 
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1. Introduction 
Diffuse correlation spectroscopy (DCS) [1,2]—also known as diffuse wave spectroscopy [3–
10]—is emerging as a reliable noninvasive technique for continuous monitoring of perfusion 
changes in deep tissue [11–31]. The continuous measurement capability of DCS could be 
beneficial  in  areas  such  as  neurointensive  care  to  assist  with  the  management  of  patients 
recovering  from  brain-injury  [32].  In  these  patients,  multiple  factors  including  systemic 
hypotension, increased intracranial pressure, impaired autoregulation and spontaneous vessel 
constriction can cause cerebral ischemia [33,34]. Since the brain is extremely vulnerable to 
ischemic  injury due to its  high energy demands and limited substrate  storage, continuous 
monitoring of cerebral blood flow (CBF) could improve outcome by providing the ability to 
detect ischemia before permanent tissue damage occurs. However, the capability of DCS to 
determine if CBF has fallen to ischemic levels is hampered by the current inability to interpret 
DCS measurements in terms of absolute blood flow. 
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measuring  absolute  CBF  using  a  light-absorbing  dye,  indocyanine  green  (ICG),  as  an 
intravascular contrast agent [35]. The accuracy of the technique has been demonstrated in 
multiple  studies  by  comparison  to  CBF  measurements  acquired  with  perfusion  computed 
tomography [35–37]. Initially developed for second-derivative NIR spectroscopy, it has also 
been extended to time-resolved (TR) NIR technology [38,39], which provides better depth 
sensitivity [40]. Although quantitative, a limitation with this technique is the need to inject a 
bolus of ICG every time CBF is measured. Since the clearance of ICG (mainly by liver) from 
the blood circulation takes 10-20 min, CBF measurements can only be obtained infrequently. 
Considering that DCS and TR-NIR technologies are compatible, our goal was to combine 
the  continuous  monitoring  ability  of  DCS  with  the  quantitative,  single  time-point 
measurement capability of the dynamic contrast-enhanced technique in order to provide a 
method for continuous monitoring of absolute CBF. With this approach, quantitative CBF 
measurements obtained by the TR-NIR technique are used to convert DCS data into units of 
absolute  blood  flow.  The  effectiveness  of  this  approach  will  depend  upon  the  agreement 
between perfusion changes measured by the two techniques. To address this issue, concurrent 
DCS and TR-NIR measurements were acquired in newborn piglets in which CBF was altered 
by changing the arterial carbon dioxide tension (paCO2) and by occluding the carotid arteries. 
This animal model was chosen to minimize signal contamination from extracerebral tissues. 
The  agreement  between  the  two  techniques  was  assessed  by  converting  TR-NIR  CBF 
measurements  into  relative  blood  flow  changes,  which  were  compared  to  corresponding 
perfusion changes measured by DCS. 
2. Materials and methods 
2.1. Instrumentation 
A detailed description of the time-resolved instrument and its characterization can be found in 
Ref. [39]. In brief, the light source of the time-resolved instrument was a picosecond diode 
laser  (LDH-P-C-810,  PicoQuant,  Germany)  emitting  at  802  nm,  the  peak  absorption 
wavelength of ICG in plasma. The laser output power and the pulse repetition rate were set to 
1.4 mW and 80 MHz, respectively. The laser beam was attenuated by two variable neutral 
density filters (NDC-50-4M, Thorlabs, Newton, NJ) and coupled into a 1.5-m long multimode 
fiber  (core  =  400  µm  and  N.A.  =  0.22;  Fiberoptics  Technology,  Pomfret,  CT).  Photons 
emerging from tissue were collected by a similar optical fiber whose distal end was secured in 
front of an electromechanical shutter (SM05, Thorlabs). Light transmitted through the shutter 
was collected by a Peltier-cooled photomultiplier tube (PMT) (PMC-100, Becker & Hickl, 
Germany). The shutter was kept closed to protect the PMT from exposure to intense light and 
was only open during TR measurements. The output of the PMT and the synchronization 
signal  from  the  laser  driver  (PDL  828,  PicoQuant)  were  sent  to  a  time-correlated  single 
photon counting module (SPC-134, Becker & Hickl) that computed the temporal point spread 
function (TPSF). The shape of the TPSF depends on the optical properties (i.e., the absorption 
coefficient,  µa,  and  the  reduced  scattering  coefficient,  µs)  of  the  medium  probed  by  the 
detected photons [41,42]. 
The  light  source  of  the  DCS  instrument  was  a  continuous-wave  laser  (DL785-100-S, 
CrystaLaser, Reno, NV) emitting at 786 nm. The coherence length of the laser (> 5 m) was 
much longer than typical photon pathlengths and the maximum output power was 100 mW. 
The laser beam was attenuated with a variable neutral density filter (NDC-50-4M, Thorlabs) 
and coupled into an emission fiber similar to the one used in the time-resolved apparatus. 
Light emerging from the tissue was collected with a 4-m long single-mode fiber (SMF-28e + , 
N.A. = 0.14, core = 125 µm, single-mode cutoff wavelength at 1260 nm). Since the emission 
wavelength of the  laser  was  much shorter than  the single-mode cutoff  wavelength of the 
detection  fiber,  the  latter  was  expected  to  guide  more  than  one  propagating  mode.  The 
detection fiber was wrapped around into a 15-cm diameter cylinder to increase the losses in 
the higher-order modes and to convert them into non-propagating modes. Light collected by 
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Geneva, Switzerland) for the first three animals and by  a single photon counting  module 
(SPCM-AQR-15-FC, PerkinElmer Canada Inc, QC, Canada) for the remaining of the study. 
The output of the detector was sent to a photon correlator board (DPC-230, Beker & Hickl, 
Germany)  that  computed  the  normalized  intensity  autocorrelation  function.  This  function 
contained information about the dynamics of the scatterers (mainly red blood cells) in the 
region probed by the detected photons [12]. 
2.2. CBF measurement with the time-resolved NIR technique 
2.2.1. Tracer-kinetics model 
The hemodynamics of an organ can be quantified by tracking the passage of a contrast agent 
through the vascular bed – an approach that has been adapted to imaging modalities including 
magnetic resonance imaging (MRI) and computed tomography (CT). With this method, the 
time-dependent concentration of contrast agent in tissue, Q(t), is related to its concentration in 
arterial blood, Ca(t), by the following expression [43]: 
  ( ) ( ) ( ), a Q t C t F R t       (1) 
where * is the convolution operator, F is blood flow and R(t) is the impulse residue function, 
which  represents  the  fraction  of  contrast  agent  remaining  in  the  tissue  at  time  t.  In  our 
dynamic contrast-enhanced experiments, Q(t) was measured by the TR-NIR instrument and 
Ca(t) obtained noninvasively using a dye densitometer (DDG 2001, Nihon Kohden, Japan). 
The function F·R(t) was extracted from the tissue and arterial ICG concentration curves using 
a stable deconvolution algorithm [44]. The initial height  of the  function is CBF  since by 
definition R(0) = 1, and the area under F·R(t) equals the cerebral blood volume (CBV) [35]. 
2.2.2. Measuring the time-dependent concentration of ICG in brain 
The time-dependent tissue concentration of ICG was measured by continuously acquiring a 
series  of  TPSFs  with  a  temporal  resolution  of  0.4  s,  10  s  prior  to  and  for  60  s  after  an 
intravenous bolus injection of ICG (0.5 ml, containing 0.05 mg of ICG per kg of animal 
weight). Tissue optical properties (µa and µs) were obtained by fitting the measured TPSFs 
with  the  solution  to  the  diffusion  equation  for  semi-infinite  homogeneous  media  using 
extrapolated-zero boundary conditions [42]. To account for the finite width of the laser pulse 
and its broadening by the fibers and the detection system, the instrument response function 
(IRF)  of  the  apparatus  was  measured  and  convolved  with  the  analytical  solution  [45].  A 
nonlinear optimization routine (MATLAB
® function fminsearch) was used to fit the model 
convolved with the IRF to each measured TPSF. The fitting range was set to 80% of the peak 
value on the leading edge and 20% on the falling edge of the TPSFs. Determining the tissue 
ICG concentration first required measuring the baseline optical properties, µa and µs, which 
were determined from TPSFs acquired over the 10 s period prior to ICG injection. The fitting 
procedure included an additional scaling factor to account for the laser power, detection gain 
and coupling efficiency. Changes in light absorption caused by ICG were characterized using 
only µa as a fitting parameter, with µs and the scaling factor fixed to their baseline values. 
Finally,  the  measured  changes  in  the  absorption  coefficient  were  used  to  calculate  ICG 
concentration by: 
          ( ) 0 ln(10) , a a ICG Q t t           (2) 
where µa(0) represents the average baseline absorption coefficient determined prior to ICG 
injection and εICG is the extinction coefficient of ICG at 802 nm (186 OD/mM/cm [46]). 
To compare with the DCS measurements, changes in CBF relative to normocapnia were 
determined by: 
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where CBFcond is the average cerebral blood flow measured at either hypocapnia, hypercapnia 
or during carotid occlusion, and CBFnormo is the average CBF measured at normocapnia. 
2.3. Diffuse correlation flowmetry 
The dynamics of the scatterers in the region probed by the DCS instrument can be assessed by 
measuring the temporal dependence of the normalized intensity autocorrelation function: 
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which is related to the electric field autocorrelation function G1(ρ,τ) by the Siegert relation 
[15]: 
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Here β is the coherence factor and  ( , ) It   represents the average detected intensity. 
2.3.1. Diffusion approximation model 
It has been shown that in highly scattering, low absorbing media, G1(ρ,τ) is solution to the 
diffusion equation for large interoptode distances (>3/µs') [2,47]. In this study, the DCS data 
were  analyzed  using  the  analytical  solution  to  the  diffusion  equation  for  a  semi-infinite 
homogeneous medium with extrapolated-zero boundary conditions [12]: 
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Here, 
2 ' '2 2
0 36 D s a s B k k D         (for  Brownian  dynamics), 
22
10 rz   , 
22
20 ( 2 ) b r z z     , ρ is the interoptode distance measured on the surface of the piglet's 
head, zb is the distance above the surface of head at which the fluence vanishes, and z0 is the 
effective depth of the source [20]. Each acquired g2(ρ,τ) function was fit with the analytical 
model  using  µs'  and  µa  measured  with  the  TR-NIR  system  and  the  known  interoptode 
distance. This procedure yielded estimates of β and the scaled diffusion coefficient (αDB). The 
integration  range  was  between  0.5  and  10  µs. The  lower  limit  was  chosen  to  reduce  the 
influence  of  noise  at  early  correlation  times,  while  the  upper  limit  was  set  to  suppress 
contributions from photons with short pathlength, which have mainly probed extracerebral 
tissues, and to not overweight the tail of the autocorrelation curve. 
Changes in the scaled diffusion coefficient were evaluated by: 
    100 .
B cond B normo
B
B normo
DD
D
D
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


      (7) 
Here αDB-Cond is the average value of αDB measured during a condition of blood flow change 
(hypocapnia, hypercapnia or carotid occlusion) compared to normocapnia, and αDB-normo is the 
average scaled diffusion coefficient obtained at normocapnia. 
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We  also  investigated  the  correlation  between  CBF  changes  measured  with  the  TR-NIR 
method and changes in the area under the intensity autocorrelation curves. In this model-
independent approach, similar to the one adopted by Dietsche et al. [3], the area defined as 
     
2
1
2 1,
t
t
A g d       (8) 
was  calculated  for  each  intensity  autocorrelation  curve  (t1  =  0.5  µs  and  t2  =  10  µs),  and 
changes evaluated as follows: 
  100 .
normo cond
normo
AA
A
A

      (9) 
Here  Anormo  and  Acond  are  the  average  areas  under  the  autocorrelation  curves  measured  at 
normocapnia and during a condition of blood flow change, respectively. 
2.4. Animal experiments 
All animal experiments were conducted following the guidelines of the Canadian Council on 
Animal Care and approved by the Animal Use Subcommittee at the University of Western 
Ontario.  Duroc-cross  piglets  were  delivered  from  a  local  supplier  on  the  morning  of  the 
experiment. Piglets were anaesthetized with 1.75 to 2.0% isoflurane (3.0% during surgery), 
tracheotomized and mechanically ventilated on an oxygen/medical-air mixture. Two incisions 
were made lateral to the trachea and vascular occluders (1.5 mm inner diameter; In Vivo 
Metric,  Healdberg,  CA)  were  placed  around  both  carotid  arteries  proximal  to  the  carotid 
bifurcation. The occluders were used to clamp the carotid arteries and create conditions of 
ischemia. An ear vein was catheterized for ICG injections (Sigma-Aldrich, St. Louis, MO). A 
femoral artery was catheterized to monitor heart rate and blood pressure and to intermittently 
collect blood samples for gas (paCO2, paO2), pH and glucose analysis. If the blood glucose 
levels fell below 4.5 mmol/L, 1-2 ml infusion of a 25% glucose solution was administered 
intravenously. A heated water mattress was used to maintain rectal temperature between 37.5 
and 38.5°C throughout the experiment. 
After surgery, animals were placed in a prone position and a custom-made probe holder 
was strapped to the head to hold two sets (one for each instrument) of emission and detection 
probes, parasagittally, approximately 1.5 cm dorsal to the eyes. Once positioned in the holder, 
the probes were left in place throughout the entire experiment. The probe-holder was designed 
such that the emission and detection probes of each instrument were positioned at opposite 
ends (20 mm apart) of the diagonal of a rectangle, similar to the probe positions shown in Fig. 
1b of Ref. [29]. This geometry ensured that the two instruments probed roughly the same 
brain  region.  Piglets  were  allowed  to  stabilize  for  1  hour  after  surgery  before  any 
measurements were acquired. 
Cerebral blood flow was increased by raising paCO2 and decreased by either occluding the 
carotid arteries or lowering paCO2. The paCO2 was changed by adjusting the breathing rate to 
create  conditions  of  hypocapnia  (paCO2  <  30  mmHg),  normocapnia  (paCO2  ~40  mmHg), 
moderate hypercapnia (45 mmHg < paCO2 < 56 mmHg), and severe hypercapnia (paCO2 > 57 
mmHg). Once the paCO2 had reached the target range, there was a 10-min delay before any 
measurements were acquired to ensure the physiological readings were stable. In addition, a 
final blood gas measurement was acquired before changing the condition of the animal to 
confirm the stability of the paCO2 during the measurements. 
Sequential measurements with the DCS instrument, immediately followed by the TR-NIR 
technique, were made during the different blood flow conditions (Fig. 1). For each animal, 
three sets of DCS and TR-NIR data were acquired during normocapnia, two sets at severe 
hypercapnia, two sets at moderate hypercapnia, and a final two sets at either hypocapnia or 
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autocorrelation curves and one ICG blood flow measurement. Approximately 15 min were 
allowed between consecutive sets of measurements. All measurements were acquired while 
the animals were in steady-state as confirmed by the stability of the physiological parameters. 
Since the measurements were acquired sequentially, an electromechanical shutter placed in 
front of the PMT prevented any light from reaching the PMT during DCS measurements. The 
lasers were also sequentially blocked during the experiments. That is, the 786 nm CW laser 
was blocked during TR measurements and the 802 nm pulsed laser was blocked during DCS 
acquisitions. The initial count rate measured with the TR-NIR instrument was adjusted to 400 
kHz (i.e., 0.5% of the laser repetition rate) to reduce dead-time effects [39]. The arterial ICG 
concentration curves were measured by attaching the dye densitometer probe to a forefoot. 
For the DCS measurements, the collection time was set to 30 s and the typical count rate was 
~60  kHz  and  ~500  kHz  for  the  first  three  and  the  last  seven  animals,  respectively.  The 
difference in count rate was a result of the difference in quantum efficiency between the two 
detectors (see section 2.1). Each experiment was completed in less than 7 hours. 
 
Fig. 1. Experimental protocol. 
2.5. Effects of errors in the optical properties on the recovered αDB 
Simulations were conducted to investigate the effects of errors in the optical properties used in 
the fitting of the autocorrelation curves on the recovered αDB values. Normalized intensity 
autocorrelation curves, g2(ρ,τ), were generated using the diffusion approximation model (Eq. 
(5) and (6)) for three values of αDB: 25, 36 and 60 (10
9cm
2s
1). At each αDB, g2(ρ,τ) data sets 
were generated by increasing µa in increments of 0.001 cm
1 from 0.15 to 0.26 cm
1 while 
keeping µs' = 8.0 cm
1. This procedure was repeated setting µa = 0.20 cm
1 and incrementing 
µs' from 7.0 to 10.0 cm
1 in steps of 0.01 cm
1. These values were chosen to mimic the range 
encountered  in  this  study  (see  Tables  1  and  2).  Each  g2(ρ,τ)  curve  generated  in  the 
aforementioned procedure was fitted using the analytical model and assuming fixed µa (0.2 
cm
1) and µs' (8.0 cm
1), which are typical of optical properites measured at normocapnia (see 
Table 1). The percentage error in the recovered αDB was evaluated as follows: 
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In this equation αDB fit is the value retrieved from the fitting procedure and αDB real is the input 
value (25, 36 or 60 × 10
9cm
2s
1). 
2.6. Statistical analysis 
All  data  are  presented  as  mean  ±  standard  error  (SE)  unless  otherwise  noted.  Statistical 
analyses were conducted using SPSS 16.0 (SPSS, Chicago, IL) and statistical significance was 
defined as p < 0.05. Physiological variables under the different capnic levels were compared 
using  a  two-tailed  paired  t-test  including  Bonferroni  correction  for  multiple  comparisons. 
Regression analyses were conducted to investigate correlations between CBF values from the 
TR-NIR technique and relative flow parameters from DCS. 
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Measurements were acquired in ten newborn piglets (8 females and 2 males), less than 6 days 
old (average age = 1.5 day, range 0-5 days) with an average weight of 1.59 ± 0.40 kg (mean ± 
standard deviation, SD). Average optical properties and physiological parameters measured at 
hypocapnia, normocapnia, moderate and severe hypercapnia, and during carotid occlusion are 
summarized in Table 1. 
Table 1. Optical properties and physiological parameters measured at hypocapnia, 
normocapnia, moderate and severe hypercapnia, and during carotid occlusion. Data are 
presented as mean ± SD. 
   µa (cm
1)  µs' (cm
1) 
paCO2 
(mmHg)  pH 
HR 
(bpm) 
MAP 
(mmHg) 
paO2 
(mmHg) 
Hypocapnia (n = 3)  0.19 ± 0.03  8.9 ± 1.5  27 ± 4  7.59 ± 0.09  201 ± 53  43 ± 5  150 ± 45 
Normocapnia (n = 10)  0.20 ± 0.03  7.9 ± 1.2  39 ± 2  7.44 ± 0.08  167 ± 29  42 ± 5  121 ± 41 
Moderate Hypercapnia 
  (n = 7) 
0.23 ± 0.03*  8.6 ± 1.1  52 ± 2*  7.36 ± 0.04*  152 ± 29*  39 ± 5  100 ± 32* 
Severe Hypercapnia 
  (n = 7) 
0.23 ± 0.04*  7.8 ± 1.0  63 ± 7*  7.29 ± 0.03*  176 ± 29  48 ± 5*  110 ± 28 
Carotid Occlusion 
  (n = 4) 
0.23 ± 0.09  7.4 ± 2.1  39 ± 2  7.46 ± 0.04  166 ± 7  38 ± 14  117 ± 48 
In Table 1* indicates significant differences relative to the mean value at normocapnia. 
The  statistical  tests  did  not  include  data  from  the  hypocapnic  and  vascular  occlusion 
conditions due to the small sample size under these conditions. As expected, hypercapnia 
caused significant changes in the arterial carbon dioxide tension and arterial pH. Significant 
changes in heart rate (HR), mean arterial pressure (MAP) and arterial oxygen tension (paO2) 
were also found. 
Figure 2 shows a typical intensity autocorrelation curve measured under normocapnia and 
the best fit to Eq. (5) and (6), which yielded estimates of β and αDB. The correlation factor 
obtained from the data shown in Fig. 2 (β = 0.158  1/6) was in good agreement with the 
theoretical prediction based on the number of guided modes for the six-mode detection fiber 
used in this study [48]. This agreement shows that the higher waveguide modes (LP02 and 
LP21) had been efficiently converted into non-propagating modes. 
 
Fig. 2. Typical intensity autocorrelation function measured at a source-detector distance of 2 
cm on a piglet head and the best-fit curve obtained using the correlation diffusion model for a 
homogeneous semi-infinite medium assuming Brownian dynamics. 
Normalized intensity autocorrelation functions and the corresponding tissue ICG curves 
measured in one animal at hypocapnia, normocapnia and hypercapnia are displayed in Fig. 3. 
As expected when CBF increased, the autocorrelation function decayed faster and the derived 
scaled diffusion coefficient increased (i.e., αDB-hyper > αDB-normo > αDB-hypo ). A similar trend 
was observed in the corresponding TR-NIR measurements (Fig. 3B). As paCO2 increased, the 
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CBF  between  the  different  capnic  levels.  These  qualitative  observations  are  in  good  
 
 
Fig. 3. (A) Typical normalized intensity autocorrelation functions and (B) the corresponding 
tissue ICG curves measured at hypocapnia, normocapnia and hypercapnia in one animal. Each 
of the curves in (A) was obtained by averaging a set of 5 normalized intensity autocorrelation 
curves to improve the signal-to-noise ratio. 
Table 2. αDB and CBF values obtained from the experimental data presented in Fig. 3 
   Hypocapnia  Normocapnia  Hypercapnia 
αDB (10
9 cm
2 s
1)  29.9  36.5  57.5 
CBF (ml/min/100g)  35.2  45.6  65.5 
agreement with the measured values given in Table 2. Note, the coefficient of variation for the 
αDB  values  derived  from  a  set  of  5  temporal  intensity  autocorrelation  curves  was 
approximately 2%. This small value demonstrates that the signal-to-noise-ratio (SNR) of the 
DCS data was sufficient to obtain precise estimates of αDB. 
Relative  CBF  changes  measured  by  the  TR-NIR  technique  were  compared  to  the 
corresponding changes in αDB (Fig. 4A). The apparent clustering of the data into three groups 
was due to the narrow paCO2 range for the three capnic levels (see Table 1). This graph 
reveals a very strong linear correlation (R
2 = 0.93) between perfusion changes and changes in 
αDB, with a slope of 1.05 ± 0.06 and an intercept of 6.4 ± 4.3%. Statistical tests revealed that 
the slope was not significantly different from unity and the intercept was not significantly 
different  from  zero.  The  correlation  between  CBF  changes  measured  by  the  TR-NIR  
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Fig. 4. Perfusion changes measured with the TR-NIR technique compared to the corresponding 
changes  in  (A)  the  scaled  diffusion  coefficient  (αDB)  and  (B)  area  under  the  intensity 
autocorrelation curves (A). 
technique  and  changes  in  the  model-independent  parameter  ΔA  extracted  from  the 
autocorrelation function is shown in Fig. 4B. The analysis revealed that changes in the area 
under the intensity autocorrelation curves were strongly correlated with blood flow changes 
(R
2 = 0.86), although the intercept was significantly different from zero (p = 0.04). 
Figure  5  shows  the  relationship  between  absolute  CBF  measured  with  the  TR-NIR 
technique and the corresponding αDB values. Since the apparatus used in this study was a 
hybrid  TR-DCS  instrument,  the  αDB  data  in  Fig.  5A  (a  slope  of  1.14  ±  0.08 
(ml/min/100g)/(10
9cm
2s
1) and an intercept of 5.95 ± 3.24 ml/min/100g) were obtained using 
the  measured  µa  (for  each  condition)  and  µs'  (for  each  piglet)  in  the  fitting  of  the 
autocorrelation curves. The benefit of using individual’s optical properties in the fitting of the 
DCS data was investigated by repeating the analysis using average values across all piglets 
(see Fig. 5B: a slope of 1.20 ± 0.12 (ml/min/100g)/(10
9cm
2s
1) and an intercept of 2.15 ± 
4.77 ml/min/100g). In this case, the correlation between the two techniques was weaker, as 
evident  by  a  reduction  in  R
2  (0.81  vs.  0.89),  despite  the  relative  homogeneity  of  the 
population. In both Figs. 5A and B, the intercept was not significantly different from zero. 
Only data from the last seven animals were used in the comparison presented in Fig. 5 
since the DCS measurements from these animals were acquired using a detector with high 
photon  detection  efficiency  (~50%)  to  provide  high  SNRs.  In  contrast,  the  first  three 
experiments were conducted using a detector with low photon detection efficiency (~7%). The 
lower SNR in these experiments caused a bias in the early time-points of the autocorrelation 
curves (i.e., the measured g2 value was much greater than the predicted value of 1 + β), which 
causes a subsequent bias in αDB. Compared to the data in Fig. 5A, including data from the 
first  three  animals  in  the  analysis  resulted  in  a  slope  of  0.86  ±  0.11 
(ml/min/100g)/(10
9cm
2s
1), an intercept of 11.45 ± 4.63 ml/min/100g and greater variability 
in the correlation (R
2 of 0.65 compared to 0.89). 
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Fig. 5. Correlation between CBF and corresponding values of absolute  αDB: (A)  αDB  was 
obtained using the measured optical properties for each animal and (B) αDB was determined 
assuming µa = 0.19 cm
1 and µs' = 7.4 cm
1 across all animals. Data are presented from the 
seven experiments using the single photon counting module with high quantum efficiency. 
Figure 6 displays the errors in the recovered αDB values caused by errors in the optical 
properties used in the fitting of the autocorrelation curves. Since the percentage errors in the 
recovered αDB were independent of the initial value, the results for only one αDB are shown in 
the figure. Figure 6A indicates that if the µa value used in the fitting procedure is smaller than 
the  true  value,  then  the  retrieved  αDB  would  be  underestimated,  while  the  opposite 
relationship is true for errors in µs' (Fig. 6B). As expected, the magnitude of the error in αDB 
caused by the latter is much greater since µs' >> µa. The error analysis also indicated that 
relative changes in αDB are not affected by errors in the assumed µa and µs' values, provided 
these values do not change during the course of an experiment. However, a change in either µa 
or µs' will cause the same magnitude of error in Δ(αDB) as shown in Fig. 6 for absolute αDB. 
 
Fig. 6. Effects of errors in the optical properties used in the fitting of the autocorrelation curves 
on the recovered αDB: g2(ρ,τ) curves were generated by (A) incrementing µa from 0.15 to 0.26 
cm
1 while keeping µs' = 8 cm
1, and (B) increasing µs' from 7 to 10 cm
1 while keeping µa = 
0.2 cm
1. All autocorrelation curves were fitted with the same µa and µs' values (0.2 and 8 cm
1, 
respectively). 
4. Discussion 
In this study, concurrent TR-NIR and DCS measurements were acquired in a neonatal animal 
model in which CBF was manipulated over a wide range from 17 to 90 ml/100g/min. The 
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technique and corresponding changes in αDB. These results are in good agreement with Zhou 
and al [17], who also reported in the same animal model a strong correlation (R
2 = 0.81, slope 
= 1.1) between perfusion changes measured with fluorescence microspheres and changes in 
αDB.  Diffuse  correlation  flowmetry  has  also  been  validated  against  other  blood  flow 
techniques  including  the  MRI-based  arterial  spin  labeling  method  [14,18,49],  transcranial 
Doppler (TCD) [11,29,50], laser Doppler flowmetry [30], and xenon-CT [51]. However, the 
current study is the first to report a comparison of DCS with another optical technique that 
measures CBF in a similar tissue volume to that probed by the DCS signal. Since the TR-NIR 
and  DCS  instruments  use  similar  probe  wavelengths  and  single-photon  detectors,  partial 
volume errors between the two techniques should be minimal compared to comparison studies 
involving imaging modalities or TCD. This difference may explain the stronger correlation 
reported here compared to previous findings [11,14,18,24,50,51]. 
The results of Fig. 4A suggest that a reference CBF measurement acquired with the TR-
NIR technique can be used to convert relative perfusion changes obtained with DCS into 
absolute values. This approach requires injecting the contrast agent ICG in order to measure 
CBF.  However,  this  is  a  minimally  invasive  procedure  since  ICG  can  be  injected  into  a 
peripheral vein and the arterial ICG time-concentration curve can be measured noninvasively 
by a DDG. Furthermore, ICG is FDA-approved, has a strong safety record, and has very low 
acute toxicity (median lethal dose in mice is 650 mg/kg) [52]. The accuracy of this combined 
TR-NIR/DCS approach will depend on the precision of the CBF measurement acquired by the 
bolus-tracking technique. Using a repeat-measures ANOVA, our group previously determined 
the  precision  to  be  9.7%,  which  is  quite  reasonable  [35].  In  addition,  subsequent 
measurements of CBF could be acquired with the TR-NIR technique if relative blood flow 
abnormalities  were  suspected  by  the  DCS  measurements.  A  potential  complication  with 
combining DCS with the bolus-tracking method is the effects of ICG-induced changes in µa 
on the αDB measurements. In these validation experiments, each ICG injection was followed 
by a delay of 15 min to allow sufficient time for the dye to clear. However, delays of this 
magnitude are extremely conservative and DCS data collection could begin very shortly after 
the acquisition of the dynamic TR-NIR data with minimal effect on αDB. This is because the 
change in µa following the first pass of ICG (see Fig. 3B) is approximately 5%, which would 
lead to an error in αDB of only 2%, according to Fig. 6. 
The strong linear correlation between CBF and absolute αDB shown in Fig. 5A suggests 
that an alternative approach would be to use  αDB directly as a  measure of CBF. Since a 
theoretical  model  relating  αDB  to  the  underlying  tissue  hemodynamics  does  not  currently 
exist, this approach would require generating a population-based calibration curve to convert 
αDB into CBF. Analogous to the piglet experiments, the general relationship between CBF 
and absolute αDB for a specific population, such as neonates, would have to be established. 
The advantage of this approach is that, once the calibration curve was generated, it would not 
be necessary to obtain a CBF measurement with the bolus-tracking technique in subsequent 
experiments.  This  approach  would  require  accurate  measurements  of  the  tissue  optical 
properties in every experiment, such as by time-resolved or frequency domain methods [30], 
since uncertainties in µa and µs' can lead to substantial errors in αDB, as shown in Fig. 6. 
These simulations can also be used to predict the error in relative αDB if the optical properties 
changed during the course of the experiment. If the values of the tissue optical properties 
remained within the range of values measured in the piglet experiments, the errors would be 
relatively small. For example, the change in µa from normocapnia to hypercapnia was 15% 
(Table 1), which translates into an error in relative αDB of only 5%. 
The calibration-curve approach also requires that the DCS data be acquired at high count-
rates to provide sufficient stability in the retrieval of αDB. The sensitivity of αDB to count rate 
was evident in this study by the substantial reduction in the correlation between CBF and αDB 
when  data  acquired  with  the  low  quantum  efficiency  detector  were  included  in  the 
comparison. Noise in the autocorrelation function introduces a bias that affects the accuracy 
of the absolute αDB values. However, the effects are minimal on relative αDB measurements 
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achieved by adjusting the laser power. Greater SNR can be obtained by using detectors with 
high  quantum  efficiency  or  multiple  detectors  in  parallel  [8]. The  count  rate  can  also  be 
improved  by  using  few-mode  detection  fibers  instead  of  truly  single-mode  fibers  [3]. 
However, the increased count rate due to the larger active area of the detection fiber comes at 
the expense of an increased number of guided modes and, consequently, reduced correlation 
factor. For the few-mode detection fiber used in this study, β was expected to be ~0.167 (for 
an ideal six-mode fiber) [48], which was in good agreement with the measured value (β = 
0.158). The small discrepancy between the predicted and experimental β values had no effect 
on  the  perfusion  measurements  and  was  likely  due  to  a  more  efficient  coupling  of  the 
fundamental LP01 mode compared to the two LP11 modes. 
A potential complication with both the reference-CBF measurement and calibration-curve 
approaches is tissue heterogeneity, due to the presence of a substantial extracerebral layer in 
the region probed by the detected photons. While the contribution of extracerebral tissues is 
not expected to be substantial in neonates, it cannot be ignored in juvenile and adult subjects. 
Extracerebral contamination has been shown to cause substantial underestimations of CBF by 
ICG  bolus-tracking  techniques  [53]  and  affect  the  accuracy  of  brain  optical  properties 
measurements [41]. A study involving computer simulations and layered tissue-mimicking 
phantoms  also  suggested  that  the  accuracy  of  DCS  can  be  degraded  by  extracerebral 
contamination [26]. It may be possible to overcome this limitation by applying multi-layer 
diffusion models and using depth-sensitive optical techniques [10,37,40,41]. 
Besides investigating αDB as a relative flow marker, we also compared changes in the area 
under  the  intensity  autocorrelation  curves  (ΔA)  to  CBF  changes.  This  model-independent 
approach is appealing due to its conceptual simplicity and does not require any knowledge 
about the optical properties of the medium. The results of Fig. 4B show a strong correlation 
between perfusion changes and changes in ΔA, but unlike in the case of αDB the correlation 
between ΔA and relative CBF was better represented by a second-order polynomial (R
2 = 
0.89) rather than a linear curve (R
2 = 0.86), suggesting a non-linear scaling of CBF with ΔA. 
A  potential  limitation  with  this  study  was  the  use  of  two  different  methods  to  create 
conditions of low CBF. In the first seven animals, vascular cuffs placed around the common 
carotids were used to lower CBF. However, in three of these animals neither technique (DCS 
or TR-NIR) detected a change in CBF after the vascular occluders were inflated, which was 
likely due to collateral flow through the vertebral arteries. Consequently, hypocapnia rather 
than carotid occlusion was used to reduce CBF in the remaining three animals. Since the 
purpose of the study was to investigate the agreement between the two techniques over a 
range of CBF values, altering the method used to reduce CBF should not affect the main 
conclusion of the study. A second potential limitation was the exclusion of data from the first 
three animals in the comparison between absolute αDB and CBF. It was necessary to exclude 
these data due to poor SNR caused by low count rates. In the remaining seven animals, DCS 
data were acquired using a detector with a high photon detection efficiency, which improved 
the SNR and reduced the variability in the retrieved αDB values. Another potential limitation 
was that the tissue optical properties used in the fitting of the autocorrelation curves were 
measured at 802 nm, and not at the emission wavelength of the DCS instrument (786 nm). 
However, it is reasonable to assume that the difference in optical properties between these two 
wavelengths is small and, consequently, the error in the DCS measurements is minimal. For 
example, we have measured the optical properties at 802 and 760 nm (data not presented) and 
the difference in µa was less than 5%, which would cause an error of less than 3% in αDB. 
A final consideration is the fact that α depends on the fraction of moving scatterers in the 
probed region, i.e., the cerebral blood volume (CBV). In this study, a good correlation was 
observed between the CBV measurements obtained from the bolus-tracking method and αDB 
(R
2 = 0.66, data not presented). However, this correlation is not surprising considering the 
well-known coupling of CBV and CBF during variations in arterial blood CO2 tension [54], 
and a good correlation between CBV and CBF was also observed in this study (R
2 = 0.77). It 
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condition in which CBV and CBF become uncoupled, such as during ischemia [55]. 
5. Conclusion 
In this study we demonstrated that DCS data could be converted into cerebral blood flow 
using an all-optical technique approach. An extension of this approach would be to combine 
DCS with a TR-NIR system equipped with multiple lasers. This combination would enable 
continuous monitoring of both CBF and cerebral blood oxygenation, from which the cerebral 
metabolic rate of oxygen could be determined. The ability to continuously measure absolute 
blood flow and oxygen utilization could help improve the outcome of patients at risk of brain 
injury by early identification of cerebral ischemia. 
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